L-Kynurenine/Aryl Hydrocarbon Receptor Pathway Mediates Brain Damage After Experimental Stroke
Author(s) -
María Isabel Cuartero,
Iván Ballesteros,
Juan de la Parra,
Andrew L. Harkin,
Áine Abautret-Daly,
Eoin Sherwin,
Pedro M. FernándezSalguero,
Angel L. Corbı́,
Ignacio Lizasoaín,
Marı́a A. Moro
Publication year - 2014
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.114.011394
Subject(s) - aryl hydrocarbon receptor , neuroprotection , kynurenine , medicine , aryl hydrocarbon receptor nuclear translocator , receptor , in vivo , central nervous system , transcription factor , signal transduction , endogeny , pharmacology , microbiology and biotechnology , neuroscience , biology , biochemistry , tryptophan , genetics , gene , amino acid
Aryl hydrocarbon receptor (AhR) is a transcription factor that belongs to the basic helix-loop-helix PAS (Per-Arnt-Sim homology domain) family known to mediate the toxic and carcinogenic effects of xenobiotics. Interestingly, AhR is widely expressed in the central nervous system, but its physiological and pathological roles are still unclear.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom